Sagimet Biosciences Inc Series A Common Stock
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $2,000 |
Gross Profit | 1,965 | |||
EBITDA | -10,589 | -8,768 | -9,467 | -7,456 |
EBIT | -21,178 | -17,536 | -18,933 | -7,491 |
Net Income | -8,118 | -6,629 | -8,151 | -6,353 |
Net Change In Cash | 0 | 0 | 0 | 2,000 |
Free Cash Flow | -5,634 | -6,208 | -7,083 | -3,879 |
Cash | 95,959 | 176,777 | 75,139 | 101,842 |
Basic Shares | 31,913 | 29,039 | 18,194 | 18,194 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $2,000 | $0 | $0 | $0 |
Gross Profit | 2,000 | -130 | -134 | -124 |
EBITDA | -30,744 | -31,055 | -23,719 | -11,370 |
EBIT | -61,484 | -31,055 | -23,719 | -11,494 |
Net Income | -27,876 | -30,499 | -24,442 | -11,370 |
Net Change In Cash | 2,000 | 0 | 0 | 0 |
Free Cash Flow | -23,766 | -24,490 | -21,710 | -10,416 |
Cash | 75,139 | 158 | 56,731 | 68,702 |
Basic Shares | 23,617 | 22,174 | 22,174 | 22,174 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.25 |
2024-03-31 | -$0.23 |
2023-12-31 | -$0.78 |
2023-09-30 | -$0.35 |
